The Journal of Neuroscience, July 2, 2003, 23(13):5662-5673
Previous Article | Next Article 
Brain-Derived Neurotrophic Factor Mediates Activity-Dependent Dendritic Growth in Nonpyramidal Neocortical Interneurons in Developing Organotypic Cultures
Xiaoming Jin,1
Hang Hu,1
Peter H. Mathers,2,3,4,5 and
Ariel Agmon1,5
Departments of 1Neurobiology and Anatomy,
2Otolaryngology, 3Biochemistry
and Molecular Pharmacology, and 4Ophthalmology, and
5The Sensory Neuroscience Research Center, West
Virginia University, Morgantown, West Virginia 26506-9128
 |
Abstract
|
|---|
Brain-derived neurotrophic factor (BDNF) promotes postnatal maturation of
GABAergic inhibition in the cerebral and cerebellar cortices, and its
expression and release are enhanced by neuronal activity, suggesting that it
acts in a feedback manner to maintain a balance between excitation and
inhibition during development. BDNF promotes differentiation of cerebellar,
hippocampal, and neostriatal inhibitory neurons, but its effects on the
dendritic development of neocortical inhibitory interneurons remain unknown.
Here, we show that BDNF mediates depolarization-induced dendritic growth and
branching in neocortical interneurons. To visualize inhibitory interneurons,
we biolistically transfected organotypic cortical slice cultures from neonatal
mice with green fluorescent protein (GFP) driven by the glutamic acid
decarboxylase (GAD)67 promoter. Nearly all GAD67GFP-expressing neurons
were nonpyramidal, many contained GABA, and some expressed markers of
neurochemically defined GABAergic subtypes, indicating that
GAD67GFP-expressing neurons were GABAergic. We traced dendritic trees
from confocal images of the same GAD67GFP-expressing neurons before and
after a 5 d growth period, and quantified the change in total dendritic length
(TDL) and total dendritic branch points (TDBPs) for each neuron.
GAD67GFP-expressing neurons growing in control medium exhibited a 20%
increase in TDL, but in 200 ng/ml BDNF or 10 mM KCl, this increase
nearly doubled and was accompanied by a significant increase in TDBPs.
Blocking action potentials with TTX did not prevent the BDNF-induced growth,
but antibodies against BDNF blocked the growth-promoting effect of KCl. We
conclude that BDNF, released by neocortical pyramidal neurons in response to
depolarization, enhances dendritic growth and branching in nearby inhibitory
interneurons.
Key words: biolistic; BDNF; GABA; GAD67; gene gun; inhibitory interneuron; neocortical development; neurotrophins; organotypic slice
 |
Introduction
|
|---|
GABAergic inhibition in the rodent cerebral cortex, although already
functional at birth (Agmon et al.,
1996
; Wells et al.,
2000
), exhibits a protracted period of postnatal maturation
lasting for several weeks (Komatsu and
Iwakiri, 1991
; Agmon and
O'Dowd, 1992
; Sutor and
Luhmann, 1995
; Cohen et al.,
2000
). Some of the developmental changes in inhibition occur
postsynaptically, but others are presynaptic and include biochemical,
morphological, and electrophysiological differentiation of GABAergic
interneurons (Miller, 1986
;
Balcar et al., 1992
;
Micheva and Beaulieu, 1995
;
Guo et al., 1997
;
Massengill et al., 1997
) and
formation of GABAergic synapses (Micheva
and Beaulieu, 1996
; De Felipe
et al., 1997
; Marty et al.,
2002
). The delayed maturation of inhibition may allow increased
NMDA receptor activation in the neonatal cortex, thereby opening a
developmental window of enhanced plasticity during an early postnatal critical
period (Agmon and O'Dowd, 1992
;
Kirkwood and Bear, 1994
;
Ramoa and McCormick, 1994
;
Rozas et al., 2001
).
An attractive hypothesis that accounts for the delayed maturation of
GABAergic inhibition suggests that inhibition is up-regulated by neuronal
excitation, thus establishing a negative feedback loop that counteracts the
developmental increase in glutamatergic excitation, albeit with a lag
(Marty et al., 1997
;
Bolton et al., 2000
;
Turrigiano and Nelson, 2000
).
A putative mediator of various effects of electrical activity is brain-derived
neurotrophic factor (BDNF), a neurotrophin acting on tyrosine kinase (Trk)B
receptors and implicated in neuronal development and synaptic plasticity
(Thoenen, 1995
;
Bonhoeffer, 1996
;
McAllister et al., 1999
;
Lu, 2003
). In the cerebellum
and hippocampus, activity-induced enhancement of GABAergic mechanisms can be
mimicked by exogenous BDNF and/or prevented by BDNF inhibitors (Marty et al.,
1996b
,
2000
;
Rutherford et al., 1997
;
Seil and Drake-Baumann,
2000
), suggesting that BDNF may also mediate activity-dependent
maturation of inhibition. Consistent with this hypothesis, GABAergic
maturation is accelerated in the cerebellum and cerebral cortex of
BDNF-overexpressing mice (Bao et al.,
1999
; Huang et al.,
1999
; Aguado et al.,
2003
). Conversely, GABAergic maturation is retarded in the
cerebellum and cerebral cortex of TrkB knock-out mice
(Rico et al., 2002
;
Carmona et al., 2003
) and in
the cerebellum of the stargazer mouse, a mutant that is deficient in BDNF
(Richardson and Leitch, 2002
)
[but see Olofsdotter et al.
(2000
) and Henneberger et al.
(2002
) for the apparently
opposite result of enhanced inhibition in the dentate gyrus and superior
colliculus of BDNF knock-out mice].
BDNF promotes neurochemical and dendritic differentiation of inhibitory
neurons of the cerebellum, neostriatum, and hippocampus
(Nawa et al., 1994
;
Ventimiglia et al., 1995
;
Marty et al., 1996a
;
Vicario-Abejon et al., 1998
;
Mertz et al., 2000
), but its
effects on dendritic growth of GABAergic interneurons in the neocortex remain
unexplored. Here, we used a novel preparation
(Jin et al., 2001
) to follow
the long-term dendritic development of individual GFP-expressing neocortical
interneurons in organotypic cultures. We found that both BDNF and
depolarization enhanced dendritic growth in nonpyramidal neocortical
interneurons, and that the effect of depolarization was dependent on the
release of endogenous BDNF.
 |
Materials and Methods
|
|---|
Organotypic culture preparation. Organotypic cortical slice
cultures were prepared as described previously
(Stoppini et al., 1991
;
Jin et al., 2001
). Postnatal
day 13 mouse pups were anesthetized by cooling and decapitated, and
their brains were rapidly removed and immersed in ice-cold artificial CSF
(ACSF) (containing in mM: 126 NaCl, 3.0 KCl, 1.3 MgSO4,
2.5 CaCl2, 1.2 NaH2PO4, 26 NaHCO3,
and 20 dextrose, saturated with 95% O25% CO2).
Under sterile conditions in a laminar flow hood, 350 µm-thick coronal brain
slices of parietal cortex were cut with a Vibroslice (World Precision
Instruments, Sarasota, FL). Slices were then placed on 30 mm Millicell
membrane inserts (Millipore, Bedford, MA), usually two slices per insert, and
the inserts were placed in individual wells of six-well plates containing 1 ml
of culture medium. The culture medium was composed of the following (in ml per
100 ml): 46 Eagle's basal medium, 25 Earle's balanced salt solution, 25 horse
serum, 1 mixture of penicillin (10,000 U/ml)streptomycin (10
mg/ml)glutamine (29.2 mg/ml) (all from Invitrogen, Carlsbad, CA), and 3
20% glucose solution. The slices were kept in a humidified incubator at
35°C with a 5% CO2-enhanced atmosphere, and the medium was
changed twice per week. After 23din culture, slices were transfected
using a Helios gene gun (Bio-Rad, Hercules, CA).
Gene gun-mediated transfection. GAD67GFP plasmid DNA was
cloned from a 10.3 kb segment of the mouse GAD67 promoter region
(Szabo et al., 1996
;
Katarova et al., 1998
) fused
in-frame to enhanced GFP (Clontech, Palo Alto, CA), as described previously
(Jin et al., 2001
).
Cytomegalovirus (CMV)GFP plasmid DNA (pGreen Lantern) was purchased
from Invitrogen. Gene gun cartridges were prepared according to the
manufacturer's protocol with slight modifications: for each 25 inch plastic
tube, 12 mg of gold particles (1.0 or 1.6 µm diameter) and 25 µg of
plasmid DNA (1 µg/µl in distilled water) were mixed in 100 µl of 50
mM spermidine, precipitated with 100 µl of 1 M
CaCl2, washed three times in 100% ethanol, and then resuspended in
3 ml of 0.02 mg/ml polyvinylpyrrolidone in ethanol and precipitated onto the
internal wall of the plastic tube. Slices were bombarded with one cartridge
per insert under 120 psi helium pressure through a nylon mesh that served to
reduce the mechanical effects of the gas blast.
Confocal microscopy. Confocal images were first acquired at least
2 d after gene gun transfection to allow complete GFP filling of distal
dendrites. Cultured brain slices were removed by cutting out the underlying
Millicell membrane (leaving it adherent to the culture) and placed under
sterile conditions in an imaging chamber filled with freshly oxygenated ACSF
at room temperature. The imaging chamber was made of two round glass
coverslips separated by 4 mm and held by a stainless-steel frame with a 17
mm-wide circular opening to allow imaging. Well separated neurons with bright
GFP expression were selected for imaging. Neurons were imaged with a
20x, 0.7 numerical aperture (NA) dry objective on an inverted Zeiss
(Thornwood, NY) LSM 510 laser-scanning confocal microscope, using the 488 nm
argon laser line and a 505550 nm bandpass emission filter. Image stacks
(typically 1020 optical sections per stack) were collected at
1.52.5 µm z-axis steps through the full extent of the
dendritic tree and saved for off-line tracing and analysis. Images were taken
with the lowest practical laser intensity and the shortest practical
illumination time to limit photodynamic damage, and slices were kept outside
the incubator for <1 hr per session. This imaging protocol was found not to
cause any apparent ill effects to the imaged neurons or the slice culture,
because most neurons remained viable and exhibited the same general dendritic
morphology when imaged again 5 or 10 d later (see
Fig. 3), and some remained
viable even after repeated imaging over several weeks (data not shown). At the
end of each imaging session, low-power (10x) images were taken in
fluorescence and transmission modes to record the locations of the
GFP-expressing neurons in the cortex relative to the pia and white matter. The
slices with their adherent membranes were then placed back into multiwell
plates under sterile conditions and returned to the incubator. The same
neurons were imaged again 5 d later.

View larger version (58K):
[in this window]
[in a new window]
|
Figure 3. Dendritic growth of GAD67GFP-expressing neurons in control medium
occurred only in younger cultures. A, Confocal projection of a
representative GAD67GFP-expressing neuron first imaged at EP7 (left)
and again 5 d later (right). B, Another neuron first imaged at EP22
(left) and again 10 d later (right). Scale bar: (in B) A, B,
100 µm. C, TDL growth ratio of all of the neurons in our sample
during a 5 d period in normal medium, plotted against the equivalent age at
first imaging. A TDL ratio of 1 (dashed line) indicates no change. Note that
dendritic growth was observed in neurons first imaged at EP7EP9 (left
of the vertical dotted line), but there was no change on average in neurons
first imaged at later ages (right of the vertical dotted line).
|
|
Pharmacological treatments. In some slices, one or more of the
following were added to the culture medium: 200 ng/ml recombinant human BDNF
(Alomone Labs, Jerusalem, Israel), 250 ng/ml recombinant human neurotrophin
(NT)4/5 (courtesy of Genentech, South San Francisco, CA), 50 µg/ml rabbit
anti-BDNF polyclonal antibody (Chemicon, Temecula, CA), 200 nM
K252a, and 1 µM tetrodotoxin (TTX) (both from Alomone Labs).
Treatments were refreshed on medium change. Pharmacological treatments started
the day after the first imaging session; therefore, treatments lasted 4 of the
5 d between imaging sessions. Control experiments (slices cultured in normal
medium) were interspersed throughout the treatment experiments.
Biocytin filling and histochemistry. To verify that GFP
fluorescence revealed the full dendritic morphology, a subset of
GFP-expressing neurons were filled with biocytin after confocal imaging. For
biocytin filling, slices with the underlying Millicell membranes were
transferred to a submersion recording chamber and continuously superfused with
ACSF saturated with 95% O25% CO2 at room
temperature. GFP-expressing neurons were visualized with a 40x, 0.8 NA
water immersion objective under an Olympus Optical (Melville, NY) BX50 upright
microscope equipped with fluorescence and differential interference contrast
optics and a Hamamatsu (Bridgewater, NJ) CCD camera. Patch pipettes were
pulled from 1.5 mm outer diameter glass capillary tubes (World Precision
Instruments) and filled with a solution of 136 mM potassium
gluconate, 2 mM MgCl2, 0.6 mM EGTA, 10
mM HEPES, 2 mg/ml biocytin, with pH adjusted to 7.3 and osmolarity
to 275285 mOsm. A whole-cell clamp configuration was achieved using the
Axopatch 200A patch-clamp amplifier (Axon Instruments, Foster City, CA) and
maintained for
1hr to allow for complete diffusion of biocytin. Slices
were then fixed overnight in 0.1 M PBS with 4% paraformaldehyde at
4°C. After three rinses in PBS, fixed slices were incubated for 2 hr with
ABC solution (Vector Laboratories, Burlingame, CA), followed by additional
rinses in PBS and staining with diaminobenzidine (DAB) (0.7 mg/ml) and
H2O2 (0.3%) in PBS. The reaction was stopped by
transferring the slices to cold PBS.
Immunocytochemistry. For immunocytochemistry,
GAD67GFP-transfected slices were fixed for
1 hr at room
temperature and then overnight at 4°C in 4% paraformaldehyde in PBS,
rinsed three times in PBS, and blocked for 13 hr in PBS containing
510% normal horse serum and 0.51% Triton X-100. Slices were then
incubated for 23dat 4°C with one or two of the following antibodies
(at 1:1000 in PBS containing 15% normal horse serum and 0.10.5%
Triton X-100): rabbit anti-GAD (AB108; Chemicon), mouse monoclonal
anti-parvalbumin (P3088; Sigma, St. Louis, MO), mouse monoclonal
anti-calbindin D28k (AB1778; Chemicon), rabbit polyclonal anti-calretinin
(AB149; Chemicon), rabbit polyclonal anti-somatostatin (T-4103; Peninsula
Laboratories, San Carlos, CA), rabbit polyclonal anti-neuropeptide Y (T-4070;
Peninsula Laboratories), and rabbit polyclonal anti-GABA [gift of David Pow
(University of Queensland, St. Lucia, Australia)] [this antibody was designed
for paraformaldehyde-only fixation, and its specificity was established
previously (Pow et al., 1995
;
Spirou and Berrebi, 1997
)].
After incubation with antibody, slices were washed three times in PBS,
followed by one or both of the following secondary antibodies (at 1:1000 in
PBS with 1% normal horse serum): Alexa 546 goat anti-rabbit IgG
(ab')2 fragments or Alexa 633 goat anti-mouse IgG
(ab')2 fragments (both from Molecular Probes, Eugene, OR),
for 2 hr at room temperature. The slices were then washed three times in PBS,
mounted in Vectashield (Vector Laboratories), and coverslipped.
Neuronal tracing. Neurons with strong GFP fluorescence throughout
their dendritic tree were reconstructed digitally from the confocal image
stacks using Neurolucida software (MicroBrightField, Colchester, VT).
GFP-expressing neurons that were filled with biocytin were traced a second
time with Neurolucida after processing the DAB reaction, using a 20x,
0.7 NA objective and a CCD video camera attached to an Olympus Optical AX70
microscope.
Data analysis. Quantitative analysis on the traced data were done
using Neuroexplorer software (MicroBrightField). Numerical data (total
dendritic length and branch points) generated from the second imaging session
(day 5) were divided by the values derived from the first imaging session (day
0) to yield a ratio; geometrical means and SEs of the ratios were then
calculated for each treatment group and for the control group.
Statistics. Exact, distribution-independent permutation tests were
used to compare experimental treatments with control
(Manly, 1997
;
Good, 1999
). Computations were
done using MathCad (MathSoft, Cambridge, MA). When a group mean was compared
with an expected value, the binomial sign test (Fisher's one-sample
randomization test) was used: each data point was assigned a positive or a
negative sign on the basis of its value relative to the expected mean, and the
probability that an equal or more extreme distribution of signs would occur at
random was calculated from the binomial probability function. When the means
of two groups were compared, the difference between the means was calculated
for 10,000 random permutations of the data, and the fraction of values equal
to or more extreme than the experimental observation was doubled to yield a
two-tailed p value. All of the comparisons were made pairwise, in
general between each experimental group and the control group, but in some
cases (indicated) between two experimental groups, with no adjustments for
multiple comparisons (Rothman,
1990
; Savitz and Olshan,
1998
).
 |
Results
|
|---|
Transfecting GABAergic interneurons with GAD67GFP
To visualize nonpyramidal neocortical interneurons, we transfected cortical
organotypic slices with a DNA construct in which the GAD67 promoter drives the
expression of GFP (Jin et al.,
2001
), because GAD is a high-fidelity marker for GABAergic neurons
(Mugnaini and Oertel, 1985
).
Two days after transfection, up to a few dozen neurons per slice expressed GFP
fluorescence at varying levels of intensity
(Fig. 1A). In strongly
fluorescent neurons, minute morphological details were discernible, including
dendritic filopodia and spines and fine axonal arborizations
(Fig. 1C). GABAergic
neurons in the cerebral cortex exhibit a nonpyramidal morphology
(Houser et al., 1983
;
Meinecke and Peters, 1987
;
Prieto et al., 1994
);
therefore, to confirm that GAD67GFP expression is restricted to
GABAergic interneurons, we compared the morphology of
GAD67GFP-expressing neurons with that of neurons transfected with a GFP
construct driven by the nonspecific CMV promoter (CMVGFP)
(Fig. 1B). Neocortical
neurons with a long vertical dendrite extending toward the pia and several
additional primary dendrites growing in all of the other directions were
defined as pyramidal-like (Fig.
1D), and all of the other neurons were defined as
nonpyramidal. In GAD67GFP-transfected slices, 92% of GFP-expressing
neurons were nonpyramidal (n = 212 neurons)
(Fig. 1A,C); in
contrast, CMVGFP-expressing neurons were divided about evenly between
pyramidal (45%) and nonpyramidal (55%) morphologies (n = 71)
(Fig. 1B,D). The
difference between slices transfected with GAD67GFP and CMVGFP
was highly significant (p < 1010;
Fisher's exact test). The higher percentage of nonpyramidal neurons in
CMVGFP-transfected slices compared with the known incidence of
GABAergic neurons in the rodent neocortex (1525%)
(Ren et al., 1992
;
Micheva and Beaulieu, 1995
)
could have reflected a higher efficacy of the CMV promoter in GABAergic
neurons, although misclassification of some pyramidal neurons as nonpyramidal
because of truncation of their apical dendrites during the slicing procedure,
or CMVGFP expression by spiny stellate cells (layer 4 neurons that are
glutamatergic but nonpyramidal), cannot be ruled out. Nevertheless, the small
fraction (8%) of neurons with pyramidal-like morphology among hundreds of
GAD67GFP-expressing cells strongly suggests that GAD67GFP
expression was primarily restricted to GABAergic interneurons.
GAD67GFP-expressing cells with pyramidal-like morphology were excluded
from additional study.

View larger version (147K):
[in this window]
[in a new window]
|
Figure 1. Neurons expressing GAD67GFP were nonpyramidal, but neurons
expressing CMVGFP had mixed morphologies. A, C, Neurons
labeled by transfection with GAD67GFP, imaged at low (10x) and
high (20x) power, respectively. B, D, Neurons labeled by
transfection with CMVGFP, imaged at low and high power, respectively.
The images in AD are from four different slices. Arrowhead in
A points to a pair of apparently fused neurons; arrowheads in
B indicate apical dendrites of pyramidal neurons. Arrows in
C and D indicate the initial segment of the axon, which
exits toward the pial surface in the interneuron (C) and toward the
white matter in the pyramidal neuron (D). Solid lines in this and
subsequent figures indicate the pial surface, and dashed lines indicate the
border between layer 6 and the white matter. Scale bars: (in B)
A, B, 200 µm; (in D) C, D, 100 µm.
|
|
In many slices, a small number of GFP-expressing neurons were observed to
form clusters of two to three closely situated cells that appeared to be fused
together at a single contact point on their somata or their proximal dendrites
(Fig. 1A, arrowhead).
Because such fused neurons were found in both GAD67GFP- and
CMVGFP-transfected slices, we assume that the fusion was induced by the
mechanical effect of the biolistic transfection; however, the precise
mechanism remains to be determined. Fused neurons were excluded from
additional study.
As an additional test of the neurotransmitter content of
GAD67GFP-expressing neurons, we stained them immunocytochemically with
antibodies to GABA (Fig.
2A,B) and to GAD67
(Fig. 2C,D). Forty-two
percent of GAD67GFP-expressing neurons examined were immunopositive for
GABA (n = 24), but only 26% were immunopositive for GAD67 (n
= 34). Moreover, GAD67GFP-expressing neurons staining immunopositive
for either GABA or GAD67 were among the least intensely stained neurons in
their microscopic field (Fig.
2B,D). This could reflect a low level of GAD67 (and
therefore GABA) expression in GFP-expressing neurons, possibly because of
competition for limited transcription factors between the endogenous and
exogenous GAD67 promoters.

View larger version (93K):
[in this window]
[in a new window]
|
Figure 2. Some, but not all, of the GAD67GFP-expressing neurons were
immunopositive for GABA and GABAergic subtype markers. A, C, E, G,
Dual-channel confocal images of immunofluorescence (pseudocolored red) and
GAD67GFP fluorescence (pseudocolored green). B, D, F, H, The
same fields with immunofluorescence only. Immunostaining is for antibodies
against GABA (A, B), GAD67 (C, D), and somatostatin
(EH). Arrows in B, D, F, and H indicate the
location of the GFP-expressing neuron shown in A, C, E, and
G, respectively. Note that the GFP-expressing neurons in A,
C, and E were immunopositive, but the neuron in G was
immunonegative. Light arrows in D indicate non-GFP-expressing
immunopositive neurons. Scale bar: (in H) A, B, EH,
100 µm; C, D, 40 µm. NCtx, Neocortex; S Oriens, stratum oriens;
L. VI, layer 6. Solid and dashed lines are as described in
Figure 1.
|
|
Cortical GABAergic interneurons can be classified into several different
subtypes with distinct neurochemical identities
(Kubota et al., 1994
;
Kawaguchi and Kubota, 1997
).
To test whether biolistic transfection with GAD67GFP preferentially
labeled GABAergic interneurons from one or more of these classes, we
immunostained GAD67GFP-transfected slices for the calcium-binding
proteins parvalbumin (PV), calbindin (CB), and calretinin (CR) and for the
neuropeptides somatostatin (SOM) and neuropeptide Y (NPY). In this analysis,
we also included GAD67GFP-expressing neurons in the hippocampus,
because the neurochemical composition of the hippocampus is virtually
identical to that of the neocortex, and because many of the GABAergic
interneuron classes in the hippocampus can be readily recognized on the basis
of their laminar position and morphological features
(Freund and Buzsaki, 1996
).
Between 4 and 12% of GAD67GFP-expressing neurons coexpressed any one of
these markers (PV, 7.4% of 189 cells; CB, 6.7% of 74 cells; CR, 4% of 51
cells; SOM, 12.1% of 157 cells; NPY, 4% of 25 cells).
The incidence of GABAergic subtype markers in GAD67GFP-expressing
neurons was well below the incidence of the same markers in the GABAergic
population of the mature cortex in vivo; for example, approximately
one-half of all of the GABAergic neurons are estimated to express PV in the
adult rat neocortex (Ren et al.,
1992
). Our immunostaining experiments, however, were done on
slices younger than 2 weeks of equivalent age (we define equivalent age as
postnatal day at culturing plus days in vitro), when PV mRNA and
protein are just becoming detectable in vivo
(Alcantara et al., 1993
;
del Rio et al., 1994
;
de Lecea et al., 1995
).
Moreover, PV expression is considerably reduced in neocortical slice cultures
prepared from neonatal animals, even after several weeks in culture
(Vogt Weisenhorn et al.,
1998
).
Unlike parvalbumin, globally reduced expression could not underlie the low
incidence of somatostatin in GAD67GFP-expressing cells, as demonstrated
by two contrasting examples in Figure
2EH. The large GFP-expressing neuron in
Figure 2E, with a cell
body at the oriensalveus border of CA1, was by its laminar location and
dendritic morphology a typical orienslacunosum moleculare interneuron,
a class of hippocampal interneurons known to express SOM
(Freund and Buzsaki, 1996
),
and was indeed SOM immunopositive (Fig.
2F). In contrast, the GFP-expressing neuron in
Figure 2G, with its
cell body in cortical layer 6, was by its ascending axons (inset) an
unmistakable Martinotti cell, a class of cortical interneurons also known to
contain SOM (Wahle, 1993
;
Kawaguchi and Kubota, 1996
);
however, this cell was SOM immunonegative
(Fig. 2H), although
several non-GFP-expressing neurons in the same microscopic field were clearly
immunopositive. These examples show that the low incidence of somatostatin in
GAD67GFP-expressing neurons did not result from a general low level of
immunoreactivity to this peptide, nor could it be attributable to an
inadvertent inclusion in our sample of glutamatergic neurons. Most likely, it
reflected lower levels of SOM in GAD67GFP-expressing neurons belonging
to this GABAergic subtype, possibly because of diversion of their biochemical
resources to the production of large amounts of an exogenous protein (GFP). It
should be noted that, in mice carrying a GAD67GFP transgene, neurons
coexpressing GFP and SOM are often less intensely stained (for SOM) than
non-GFP-expressing, SOM-immunopositive neurons nearby (our unpublished
observations), indicating similar competitive pressures in transgenic animals,
although the transgene is presumably present in the genome of transgenic mice
in far fewer copies than those of the GAD67GFP construct in
biolistically transfected neurons.
Dendritic development of nonpyramidal cortical interneurons in
organotypic slice cultures
Because GFP expression in our cultures revealed the detailed morphology of
living neurons, we were able to follow the morphological development of
individual neurons over time by imaging the same neuron two or more times at 5
d intervals, digitally reconstructing the three-dimensional (3-D) dendritic
morphology of the neuron from stacks of confocal images, and quantifying the
TDL and TDBPs at each imaging time point.
We first followed the growth of GFP-expressing neurons in normal medium
(Fig. 3). When first imaged,
the age of our cultures varied between equivalent postnatal day 7 (EP7)
(equivalent postnatal day = postnatal day at culturing + days in
vitro) and EP24. We quantified dendritic growth over the next5dby
calculating the ratio between TDL at second imaging (day 5) and TDL at first
imaging (day 0). This ratio is plotted in
Figure 3C against
equivalent age at first imaging. The mean TDL ratio was 1.22 ± 0.07
(n = 19 neurons) for neurons first imaged at EP10 or earlier (left of
vertical dotted line), but was 1.01 ± 0.03 (n = 26) for
neurons first imaged at older ages (right of dotted line). The difference
between the means of the two groups was highly significant (p =
0.0008). Notably, the SD of the TDL ratios in the younger group was twice as
large as in the older group, indicating a higher variability in growth rate in
younger slices. As an additional measure of growth, we also compared the TDBP
ratio of the second to the first imaging. The mean TDBP ratio (0.93 ±
0.09 and 1.03 ± 0.06, respectively, for the younger and older groups)
was not significantly different from 1 for either group (p = 0.5 and
0.18, respectively), indicating that, in our control conditions, there was a
balance between the addition and elimination of new branches, even when (as in
the younger age group) there was a net elongation of dendrites. These data
suggest that dendritic growth in our nonpyramidal cortical interneurons
occurred mostly during the first 2 weeks in organotypic culture, and that
dendritic branching patterns may have been already fully established by the
age of our earliest imaging (EP7). Because our goal was to study the role of
BDNF during normal development, all of the subsequent experiments were done on
the younger age group (EP7EP10 at first imaging).
Because organotypic slices grow thinner and more translucent with time in
culture, and because the level of GFP expression often appeared to increase
with time in culture, we were concerned that any apparent increase in
dendritic length between the two imaging sessions could be the result of
incomplete visualization or incomplete GFP filling of dendrites at the
earliest imaging time point. To test this possibility, we compared dendritic
filling and visualization between GFP and biocytin, a much smaller molecule
commonly used for reconstruction of neuronal morphology after intracellular
recordings. Seven GFP-expressing neurons were imaged with a confocal
microscope and then injected with biocytin through a patch pipette, processed
for the histochemical DAB reaction, and traced with a computerized system. The
3-D dendritic morphology was then compared between reconstructed confocal
images and biocytin tracings of the same neuron
(Fig. 4). We found that, in
older neurons, dendritic reconstructions from GFP and biocytin closely
overlapped, after adjusting for shrinkage
(Fig. 4A). In some of
the younger neurons, however, GFP tracings from confocal stacks missed a
terminal portion of one or two dendritic branches, as evident from comparison
with the biocytin image (Fig.
4B, top tracing, arrow). This was not caused by
insufficient GFP filling, but rather by loss of optical signal from dendritic
branches growing deep into the tissue, as illustrated by the
xz projection in
Figure 4B, bottom
tracing, arrow. This situation was easy to identify, because such branches
gradually disappeared from view in deeper optical sections; these branches
were thereby excluded from analysis in all of the images taken from that
particular neuron.

View larger version (11K):
[in this window]
[in a new window]
|
Figure 4. GAD67GFP fluorescence revealed the full dendritic morphology.
GAD67GFP-expressing neurons were imaged 3 weeks (A) or 3 d
(B) after transfection and then injected with biocytin through a
patch pipette. The 3-D reconstructions of the dendritic trees from the
confocal images (green) are superimposed on the 3-D reconstructions from the
biocytin tracings of the same neurons (red). Note that the GFP fluorescence
was at least as extensive as the biocytin labeling, but one secondary dendrite
in the younger neuron in B appeared shorter in the confocal image
compared with the corresponding biocytin tracing (B, top tracing,
arrow). The terminal part of the dendrite was missing from the confocal
reconstruction, because it was located deep in the slice, as shown by the
xz image of the same neuron (B, bottom
tracing, arrow). Scale bar, 100 µm (for both images).
|
|
BDNF, but not NT4/5, enhanced dendritic growth in nonpyramidal
interneurons
To investigate the role of BDNF and activity in regulating dendritic growth
of nonpyramidal interneurons, we followed the morphological development of
individual GAD67GFP-expressing neurons over a 5 d period and compared
TDL and TDBP ratios between neurons from cultures treated with 200 ng/ml BDNF,
or one of several other treatments, to neurons from untreated control
cultures. Representative neurons are illustrated in
Figure 5, and a summary plot of
all of the experiments is presented in
Figure 6. As illustrated in
Figure 5A, growth in
control conditions was modest (note the small rightward shift in the
cumulative histogram). As reported above, the mean control TDL ratio (i.e.,
TDL at day 5 divided by TDL at day 0) was 1.22 ± 0.07 (n =
19); this change was significantly different from 1 (p = 0.01), but
there was no significant change in TDBPs. In contrast,
GAD67GFP-expressing neurons developing in the presence of BDNF
(Fig. 5B) exhibited
considerably more growth. The mean TDL ratio in the presence of BDNF was 1.42
± 0.05 (n = 27), representing a fractional increase (42%)
nearly double that in control medium (22%). BDNF also promoted branching of
existing dendrites (but not addition of primary dendrites): the mean TDBP
ratio in BDNF was 1.25 ± 0.09. Both TDL and TDBP ratios in the BDNF
group were significantly different from those of the control group (p
= 0.03 and 0.01, respectively) (Fig.
6A,B). These results indicate that BDNF promotes
dendritic growth and complexity in nonpyramidal neocortical interneurons.

View larger version (18K):
[in this window]
[in a new window]
|
Figure 5. BDNF and KCl enhanced dendritic growth of GAD67GFP-expressing
neurons. Left column, Morphological reconstructions of representative
dendritic trees of neurons before (green) and after (red) a 5 d period in
culture medium supplemented by one of the following: no supplement
(A), 200 ng/ml BDNF (B), 200 ng/ml BDNF and 1
µM TTX (C), 10 mM KCl (D), or 10
mM KCl and 50 µg/ml anti-BDNF (E). Right column,
Cumulative histogram of TDL in each treatment group; each data point
represents the fraction of neurons in the treatment group with TDL values
equal to or smaller than the corresponding x value. , TDL at
day 0 (before treatment). , TDL at day 5 (after treatment). Note that
the rightward shift of the curves (indicating an overall increase in total
dendritic length) was considerably larger in B, C, and D,
compared with control. Scale bar, 100 µm (for all images).
|
|

View larger version (14K):
[in this window]
[in a new window]
|
Figure 6. Summary and statistical analysis of the effects of all of the tested
treatments on dendritic growth and branching. Ratio change in TDL (left) and
TDBPs (right) after 5 d of the treatment indicated. Each box spans the 25th to
75th percentile of the data points, with the median represented by a vertical
line inside the box; the whiskers span the 5th to 95th percentiles. The number
of neurons tested is indicated in parentheses after the treatment label. The
dashed vertical lines at x = 1 indicate no change.
(*)p < 0.1, *p < 0.05,
**p < 0.01, ***p < 0.005; p values are from
pairwise comparisons with the control group.
|
|
To test whether the growth-promoting effect of BDNF on nonpyramidal,
GABAergic interneurons depended on electrical activity, we allowed cultures to
develop in the presence of both 200 ng/ml BDNF and 1 µM TTX
(Fig. 5C). Under these
conditions, there was still enhanced dendritic growth in
GAD67GFP-expressing neurons, and the mean TDL ratio was 1.62 ±
0.11 (n = 17), significantly larger than control (p = 0.001)
(Fig. 6A) (the
increase in TDL ratio compared with BDNF alone was only marginally significant
at the p = 0.06 level). TTX did seem to prevent branching
(Fig. 6B)(p =
0.6). These data suggest that, unlike the effect of BDNF on pyramidal neurons
(McAllister et al., 1996
), the
enhancing effect of BDNF on dendritic growth of GABAergic interneurons does
not require sodium-dependent electrical activity.
To study the role of endogenous BDNF in dendritic development in culture,
we compared dendritic growth in control slices with growth in cultures in
which endogenous BDNF was neutralized with a high titer (50 µg/ml) of
anti-BDNF antibodies, shown to block the effect of endogenous BDNF
(Ghosh et al., 1994
;
Marty, 2000
;
Seil and Drake-Baumann,
2000
), or in which Trk signaling was blocked by 200 nM
Trk signaling inhibitor K252a (Knusel and
Hefti, 1992
). Under both conditions, dendritic growth was
significantly reduced compared with control
(Fig. 6A) (TDL ratios
were 1.07 ± 0.04, n = 21, p = 0.03 for anti-BDNF;
0.99 ± 0.05, n = 14, p = 0.006 for K252a), indicating
that dendritic growth in vitro is regulated by release of endogenous
BDNF into the extracellular milieu. Finally, we tested the effect of the
neurotrophin NT4/5, which also activates TrkB receptors and is expressed in
the cortex during early development
(Maisonpierre et al., 1990
;
Timmusk et al., 1993
). NT4/5
(250 ng/ml) had no enhancing effect on dendritic growth or branching of
nonpyramidal interneurons; indeed, growth in NT4/5 was significantly reduced
(Fig. 6A) (1.07
± 0.05, n = 14, p = 0.03), possibly because NT4/5
competed with endogenous BDNF for TrkB binding sites
(Janiga et al., 2000
).
Effect of neuronal activity on GABAergic neuron dendritic growth
Electrical activity can increase several parameters of GABAergic function
(Rutherford et al., 1997
;
Marty et al., 2000
), but its
effect on dendritic growth of cortical GABAergic neurons was not known. We
tested the effect of electrical activity on GAD67GFP-expressing neurons
by incubating slice cultures in a medium containing 10 mM KCl
(Fig. 5D), which
depolarizes cortical neurons and causes action potential firing
(Franklin et al., 1995
;
Tongiorgi et al., 1997
;
Vaillant et al., 2002
).
GAD67GFP neurons cultured in a high KCl medium exhibited enhanced
growth and branching compared with control (the mean TDL and TDBP ratios were
1.39 ± 0.06 and 1.22 ± 0.09, respectively; n = 24). The
effect on branch points was statistically significant (p = 0.03);
however, the effect on dendritic length was only marginally so (p =
0.08) (Fig. 6), most likely
reflecting the modest level of depolarization expected from 10 mM
KCl.
Because electrical activity enhances cortical BDNF levels
(Castren et al., 1992
;
Tongiorgi et al., 1997
), the
effect of high K+ could have been mediated through
activity-dependent release of BDNF. Consistent with this interpretation, the
effects of high KCl on dendritic growth and complexity were not significantly
different from the effects of BDNF (p = 0.76 and 0.63, respectively).
We tested the dependence of the KCl effect on released BDNF by neutralizing
endogenous extracellular BDNF with anti-BDNF antibodies
(Fig. 5E). Dendritic
development in a medium supplemented with 10 mM KCl and 50 µg/ml
anti-BDNF was nearly blocked: the TDL ratio was 1.14 ± 0.05, and the
TDBP ratio was 1.02 ± 0.06 (n = 11). TDL in high KCl plus
anti-BDNF was very significantly different from growth in KCl alone
(p = 0.002), and TDBP was marginally so (p = 0.07), but both
were not significantly different from growth and branching in anti-BDNF alone
(p = 0.3 and 0.73, respectively), consistent with the interpretation
that the dendritic growth-promoting effect of high KCl was indeed mediated by
BDNF, rather than through an independent, additive pathway (because if the
latter was the case, high KCl should have promoted some growth even in the
presence of anti-BDNF).
To test whether growth in normal culture medium is dependent on electrical
activity, we cultured slices in the presence of 1 µM TTX. Mean
TDL ratio in TTX was 0.96 ± 0.03 (n = 12), very significantly
different from control (p = 0.0002)
(Fig. 6A), indicating
that TTX counteracted the increase in TDL that occurred in normal medium and
suggesting that sodium-dependent electrical activity is required for normal
dendritic growth in culture.
Finally, to test whether BDNF and depolarization affect dendritic growth in
a similar manner, we used Sholl analysis to quantify dendritic growth within
consecutive concentric rings around the cell body, and compared Sholl plots
showing the increase in dendritic length overa5d growth period among control,
BDNF, and high K+ conditions
(Fig. 7). As illustrated,
dendritic growth was distributed within a radius of
300 µm around the
cell body, with the most growth occurring between 50 and 250 µm from the
cell body. No major differences were evident between growth patterns in BDNF
and high K+, consistent with the conclusion that growth under both
conditions was mediated by the same cellular mechanisms.
 |
Discussion
|
|---|
In this study, we tested whether exogenous BDNF or depolarization by high
KCl enhanced dendritic growth of nonpyramidal cortical interneurons expressing
GAD67GFP in organotypic slice cultures, and whether there was
cross-dependency between the effects of BDNF and depolarization. Short-term
(minutes to hours) changes in dendritic morphology were tracked previously in
living GFP-expressing cortical neurons in vitro
(Fischer et al., 1998
;
Engert and Bonhoeffer, 1999
;
Horch et al., 1999
;
Maletic-Savatic et al., 1999
;
Wu et al., 2001
) or in
vivo (Lendvai et al.,
2000
), but our study is the first, to our knowledge, to follow the
morphological development of the same neocortical neurons over 5 or more days.
By imaging the same GFP-expressing neurons at 5 d intervals, we demonstrated
that (1) both BDNF and elevated K+ enhanced dendritic growth of
nonpyramidal interneurons to the same degree, (2) the effect of BDNF was not
dependent on neuronal activity, but (3) the KCl-induced dendritic growth was
dependent on release of endogenous BDNF. Together, these observations suggest
a role for BDNF in regulating structural and functional maturation of
GABAergic interneurons in the developing neocortex and potentially mediating
activity-induced dendritic remodeling in the adult.
BDNF effects in pyramidal and nonpyramidal neocortical interneurons
are qualitatively different
Exogenous or endogenous BDNF, NT3, and NT4/5 have been shown to promote
dendritic elongation and branching in neocortical pyramidal cells developing
in organotypic cultures (McAllister et al.,
1995
,
1997
;
Horch et al., 1999
;
Niblock et al., 2000
;
Yacoubian and Lo, 2000
), but
their effects on nonpyramidal, inhibitory neocortical interneurons were not
studied previously. Our results show that activation of TrkB receptors by
BDNF, but not by NT4/5, promotes dendritic elongation and branching in
developing neocortical nonpyramidal interneurons. Although both BDNF and NT4/5
activate TrkB receptors, the two ligands often affect dendritic growth
differentially, even in the same neurons
(McAllister et al., 1995
;
Bosco and Linden, 1999
;
Steljes et al., 1999
).
In our study, a 4 d treatment with 200 ng/ml BDNF caused a 40% increase in
TDL of neocortical interneurons. In contrast, a 36 hr treatment with 200 ng/ml
BDNF doubles the TDL and TDBPs of layer 4 pyramidal neurons in the ferret
(McAllister et al., 1995
). We
noted several other differences between the published effects of BDNF on
neocortical pyramidal neurons and the effects on nonpyramidal neurons in this
study: BDNF did not increase the number of primary dendrites in nonpyramidal
neurons, but does so in pyramidal cells (McAllister et al.,
1995
,
1996
;
Horch et al., 1999
); TTX did
not prevent enhancement by BDNF of nonpyramidal cell dendritic growth, but
does prevent some of the effects of BDNF on pyramidal cells
(McAllister et al., 1996
); and
BDNF-induced dendritic branches were stable for up to several weeks in
nonpyramidal cells, but are highly unstable in pyramidal neurons
(Horch et al., 1999
).
Together, these comparisons suggest that the effects of BDNF on pyramidal and
nonpyramidal neurons are qualitatively different, possibly because these two
classes of cells express different complements of TrkB receptors or different
downstream effectors of TrkB activation.
Depolarization promotes dendritic growth in nonpyramidal neocortical
interneurons
We found that depolarizing neurons by adding 10 mM KCl to our
organotypic cultures enhanced dendritic growth and branching of nonpyramidal
interneurons to a level similar to that induced by 200 ng/ml BDNF, whereas
blocking action potentials with TTX prevented dendritic growth. Therefore,
these data suggest that dendritic growth of cortical interneurons in
organotypic cultures requires action potentials and can be enhanced by
depolarization. KCl-induced enhancement and/or TTX-induced reduction of
dendritic length and complexity have been demonstrated previously in some
systems (Reitstetter and Yool,
1998
; Mertz et al.,
2000
; Vaillant et al.,
2002
), but not in others
(Riccio and Matthews, 1987
;
Dalva et al., 1994
;
Rajan and Cline, 1998
).
Notably, TTX- or KCl-induced changes in dendritic length were not observed in
dissociated cortical neurons in vitro
(Kossel et al., 1997
;
Ramakers et al., 1998
). If, as
we propose below, the effect of depolarization was mediated by extracellular
BDNF, then the failure to observe this effect in dissociated cultures could be
attributable to the lower density of neurons in these cultures compared with
organotypic slices and to dilution of the released BDNF to ineffective
levels.
Depolarization effects are mediated by BDNF released by pyramidal
neurons
Depolarization can promote dendritic growth in a cell-autonomous manner,
e.g., by activating voltage-gated calcium channels, followed by
calcium-dependent phosphorylation of the dendritic protein MAP2
(microtubule-associated protein 2)
(Quinlan and Halpain, 1996
;
Sanchez et al., 2000
;
Wu et al., 2001
;
Vaillant et al., 2002
).
Alternatively, depolarization can enhance dendritic growth through
cellcell signaling (Matsutani and
Yamamoto, 1998
; Nedivi et al.,
1998
). The most parsimonious explanation of our results is that
activity-dependent dendritic growth in our experiments was mediated by
cellcell signaling via BDNF, because the KCl-induced growth was
prevented by antibodies to BDNF; however, it is difficult to rule out the
possibility that KCl acted via a cell-autonomous pathway, and that BDNF
provided only permissive conditions for the activation of this pathway.
In the cerebral cortex, BDNF is expressed only by pyramidal neurons, but
TrkB, the preferred receptor for BDNF, is found in both pyramidal cells and
GABAergic interneurons (Cellerino and
Maffei, 1996
; Rocamora et al.,
1996
; Gorba and Wahle,
1999
). BDNF expression and release is induced or enhanced by
excitatory synaptic and electrical activity, as has been consistently
demonstrated in vitro (Zafra et
al., 1990
; Ghosh et al.,
1994
; Wetmore et al.,
1994
; Goodman et al.,
1996
; Gorba et al.,
1999
; Balkowiec and Katz,
2002
) and in vivo
(Isackson et al., 1991
;
Castren et al., 1992
;
Suzuki et al., 1995
;
Rocamora et al., 1996
;
Yan et al., 1997
;
Rossi et al., 1999
). We
therefore propose that depolarization-induced synthesis and release of BDNF
from pyramidal neurons, either from dendrites
(Davies, 1996
;
Haubensak et al., 1998
;
Hartmann et al., 2001
;
Kojima et al., 2001
) or from
axon terminals (Fawcett et al.,
1998
; Fawcett et al.,
2000
; Kohara et al.,
2001
), activated TrkB receptors on nearby GABAergic neurons and
promoted their dendritic growth. In addition, it is possible that
depolarization also enhanced TrkB expression on the recipient interneurons
themselves (Tongiorgi et al.,
1997
; Meyer-Franke et al.,
1998
), causing them to be more responsive to ambient levels of
BDNF.
A larger dendritic tree is likely to receive more axodendritic (mostly
excitatory) synapses and thus increase electrical activity in the neuron.
Moreover, the larger dendritic trees were most likely accompanied by larger
(or denser) axonal arbors, as shown previously in dissociated cultures
(Vicario-Abejon et al.,
1998
), although, in our slice cultures, it was difficult to image
the axonal arbor in its entirety; a larger axonal arbor is likely to make more
inhibitory synapses on postsynaptic targets. Thus, the depolarization-induced
increase in network activity would be followed by an increase in synaptic
inhibition, bringing activity levels back down. This negative feedback loop is
illustrated schematically in Figure
8.

View larger version (9K):
[in this window]
[in a new window]
|
Figure 8. BDNF mediates a feedback loop that maintains a balance between excitation
and inhibition. Left, A pyramidal neuron is assumed to be depolarized (+),
causing it to increase its firing rate and thereby release more BDNF into the
extracellular space, acting on TrkB receptors in a nearby inhibitory neuron.
(Although this figure implies that BDNF is released from dendrites, BDNF may
also be released from axon terminals.) Right, The released BDNF caused the
inhibitory interneuron to ramify its dendritic and axonal arbors and thereby
increase its inhibitory effect on the pyramidal cell () counteracting
the initial depolarization.
|
|
BDNF and activity-dependent maturation of GABAergic function
Electrical and synaptic activity in vitro has been shown
previously to promote, and blockade of this activity, to reverse, an increase
in the level of expression of GABA and GABAergic markers
(Marty et al., 1996b
;
Rutherford et al., 1997
) and
an increase in the density of GABAergic synapses
(Marty et al., 2000
;
Seil and Drake-Baumann,
2000
). Similar to the effects demonstrated here, in the same
studies these effects of activity were reproduced by exogenous BDNF and
prevented by BDNF blockers, and/or, conversely, the effects of activity
blockade were reproduced by BDNF blockers and prevented by exogenous BDNF,
indicating that activity exerts its effects via BDNFTrkB signaling.
Various other aspects of GABAergic maturation were shown to be dependent on or
enhanced by BDNF in vitro (Seil
et al., 1994
; Widmer and
Hefti, 1994
; Murphy et al.,
1998
; Yamada et al.,
2002
) and in vivo
(Nawa et al., 1994
;
Huang et al., 1999
;
Aguado et al., 2003
). Thus,
BDNF may play a major role in regulating the maturation of the GABAergic
inhibitory system and may act during development to keep GABAergic inhibition
in step with the level of excitatory activity, thereby maintaining activity
homeostasis in the network (Marty et al.,
1997
; Bolton et al.,
2000
; Turrigiano and Nelson,
2000
). In the adult, BDNF may also mediate the effects of other
physiological parameters, such as hormonal state, on dendritic morphology
(Barbany and Persson, 1992
;
Toran-Allerand, 1996
;
Murphy et al., 1998
). Finally,
in addition to its global effect on the balance between excitation and
inhibition, BDNF could also act very locally, by virtue of its anterograde or
retrograde release and uptake in synapses
(Altar et al., 1997
;
Fawcett et al., 1998
;
Hartmann et al., 2001
;
Kohara et al., 2001
) and the
dendritic targeting of its receptor protein and mRNA
(Fryer et al., 1996
;
Tongiorgi et al., 1997
), to
promote growth of dendritic branches receiving active synapses at the expense
of branches opposite less active synapses. Thus, BDNF could mediate dynamic
sculpting of dendritic fields, providing a morphological substrate for
activity-dependent plasticity of neuronal circuits, both during development
and in adult learning.
 |
Footnotes
|
|---|
Received Oct. 1, 2002;
revised May. 5, 2003;
accepted May. 5, 2003.
This work was supported by National Institutes of Health Grants HD33463
(A.A.) and EY12152 (P.H.M.). We thank Albert Berrebi for helpful advice on
immunocytochemistry and comments on this manuscript. We also thank Janet Cyr
and Jason Wells for helpful comments on this manuscript; Cary Johnson, Jeff
Altemus, Colette Ramsburg, and Eric Christenson for excellent technical
support; and Dr. Gabor Szabo for providing the GAD67 promoter.
Correspondence should be addressed to Dr. Aric Agmon, Department of
Neurobiology and Anatomy, West Virginia University, Health Science Center
Drive, Morgantown, WV 26506-9128. E-mail:
aagmon{at}wvu.edu.
X. Jin's present address: Department of Neurology and Neurological
Sciences, Stanford University School of Medicine, Stanford, CA 94305
Copyright © 2003 Society for Neuroscience
0270-6474/03/235662-12$15.00/0
 |
References
|
|---|
Agmon A, O'Dowd DK (1992) NMDA receptor-mediated
currents are prominent in the thalamocortical synaptic response before
maturation of inhibition. J Neurophysiol
68: 345349.[Abstract/Free Full Text]
Agmon A, Hollrigel G, O'Dowd DK (1996) Functional
GABAergic synaptic connection in neonatal mouse barrel cortex. J
Neurosci 16:
46844695.[Abstract/Free Full Text]
Aguado F, Carmona MA, Pozas E, Aguilo A, Martinez-Guijarro FJ,
Alcantara S, Borrell V, Yuste R, Ibanez CF, Soriano E (2003) BDNF
regulates spontaneous correlated activity at early developmental stages by
increasing synaptogenesis and expression of the K+/Cl
co-transporter KCC2. Development
130:
12671280.[Abstract/Free Full Text]
Alcantara S, Ferrer I, Soriano E (1993) Postnatal
development of parvalbumin and calbindin D28K immunoreactivities in the
cerebral cortex of the rat. Anat Embryol (Berl)
188: 6373.[Medline]
Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, Lindsay
RM, Wiegand SJ (1997) Anterograde transport of brain-derived
neurotrophic factor and its role in the brain. Nature
389:
856860.[Medline]
Balcar VJ, Zetzsche T, Wolff JR (1992) Glutamate
decarboxylase in developing rat neocortex: does it correlate with the
differentiation of GABAergic neurons and synapses? Neurochem
Res 17:
253260.[Medline]
Balkowiec A, Katz DM (2002) Cellular mechanisms
regulating activity-dependent release of native brain-derived neurotrophic
factor from hippocampal neurons. J Neurosci
22:
1039910407.[Abstract/Free Full Text]
Bao S, Chen L, Qiao X, Thompson RF (1999) Transgenic
brain-derived neurotrophic factor modulates a developing cerebellar inhibitory
synapse. Learn Mem 6:
276283.[Abstract/Free Full Text]
Barbany G, Persson H (1992) Regulation of neurotrophin
mRNA expression in the rat brain by glucocorticoids. Eur J
Neurosci 4:
396403.[ISI][Medline]
Bolton MM, Lo DC, Sherwood NT (2000) Long-term
regulation of excitatory and inhibitory synaptic transmission in hippocampal
cultures by brain-derived neurotrophic factor. Prog Brain Res
128:
203218.[ISI][Medline]
Bonhoeffer T (1996) Neurotrophins and
activity-dependent development of the neocortex. Curr Opin
Neurobiol 6:
119126.[ISI][Medline]
Bosco A, Linden R (1999) BDNF and NT-4 differentially
modulate neurite outgrowth in developing retinal ganglion cells. J
Neurosci Res 57:
759769.[ISI][Medline]
Carmona MA, Martinez A, Soler A, Blasi J, Soriano E, Aguado F
(2003) Ca2+-evoked synaptic transmission
and neurotransmitter receptor levels are impaired in the forebrain of
trkb (/) mice. Mol Cell Neurosci
22: 210226.[ISI][Medline]
Castren E, Zafra F, Thoenen H, Lindholm D (1992) Light
regulates expression of brain-derived neurotrophic factor mRNA in rat visual
cortex. Proc Natl Acad Sci USA 89:
94449448.[Abstract/Free Full Text]
Cellerino A, Maffei L (1996) The action of
neurotrophins in the development and plasticity of the visual cortex.
Prog Neurobiol [Erratum (1996) 50:333]
49: 5371.[ISI][Medline]
Cohen AS, Lin DD, Coulter DA (2000) Protracted
postnatal development of inhibitory synaptic transmission in rat hippocampal
area CA1 neurons. J Neurophysiol 84:
24652476.[Abstract/Free Full Text]
Dalva MB, Ghosh A, Shatz CJ (1994) Independent control
of dendritic and axonal form in the developing lateral geniculate nucleus.
J Neurosci 14:
35883602.[Abstract]
Davies AM (1996) Paracrine and autocrine actions of
neurotrophic factors. Neurochem Res 21:
749753.[ISI][Medline]
De Felipe J, Marco P, Fairen A, Jones EG (1997)
Inhibitory synaptogenesis in mouse somatosensory cortex. Cereb
Cortex 7:
619634.[Abstract/Free Full Text]
de Lecea L, del Rio JA, Soriano E (1995) Developmental
expression of parvalbumin mRNA in the cerebral cortex and hippocampus of the
rat. Brain Res Mol Brain Res 32:
113.[Medline]
del Rio JA, de Lecea L, Ferrer I, Soriano E (1994) The
development of parvalbumin-immunoreactivity in the neocortex of the mouse.
Brain Res Dev Brain Res 81:
247259.[Medline]
Engert F, Bonhoeffer T (1999) Dendritic spine changes
associated with hippocampal long-term synaptic plasticity.
Nature 399:
6670.[Medline]
Fawcett JP, Bamji SX, Causing CG, Aloyz R, Ase AR, Reader TA,
McLean JH, Miller FD (1998) Functional evidence that BDNF is an
anterograde neuronal trophic factor in the CNS. J Neurosci
18:
28082821.[Abstract/Free Full Text]
Fawcett JP, Alonso-Vanegas MA, Morris SJ, Miller FD, Sadikot AF,
Murphy RA (2000) Evidence that brain-derived neurotrophic factor
from presynaptic nerve terminals regulates the phenotype of
calbindin-containing neurons in the lateral septum. J Neurosci
20: 274282.[Abstract/Free Full Text]
Fischer M, Kaech S, Knutti D, Matus A (1998) Rapid
actin-based plasticity in dendritic spines. Neuron
20: 847854.[ISI][Medline]
Franklin JL, Sanz-Rodriguez C, Juhasz A, Deckwerth TL, Johnson Jr
EM (1995) Chronic depolarization prevents programmed death of
sympathetic neurons in vitro but does not